Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nadia L. Jaber"'
Autor:
Bulent Arman Aksoy, Kenneth C. Smith, Stuart L. Schreiber, Zhou Ji, Olga Nikolova, Leandro C. Hermida, Daniela S. Gerhard, Aris Floratos, Vlado Dančík, Nadia L. Jaber, Jessica N. Mazerik, Paul A. Clemons, Benjamin Gross, Subhashini Jagu, Chris Sander, Andrea Califano
Publikováno v:
Database: The Journal of Biological Databases and Curation
The Cancer Target Discovery and Development (CTD2) Network aims to use functional genomics to accelerate the translation of high-throughput and high-content genomic and small-molecule data towards use in precision oncology. As part of this goal, and
Autor:
Daniela S. Gerhard, Nadia L. Jaber, Martin L. Ferguson, Jaime M. Guidry Auvil, Jessica N. Mazerik, Nicholas B. Griner, Subhashini Jagu
Publikováno v:
Cancer Research. 76:5293-5293
The Office of Cancer Genomics (OCG), within the National Cancer Institute, supports cutting-edge genomics and translational research to advance the molecular understanding of cancer, with the ultimate goal of improving clinical outcomes through preci
Autor:
Steven E. Carsons, Andrew Sohn, Iryna Voloshyna, Nadia L. Jaber, Peter A. Wirkowski, Sajan Eapen, Kamran Anwar, Allison B. Reiss, Michael J. Littlefield
Publikováno v:
Lipids. 46(2)
Cardiovascular safety of cyclooxygenase (COX)-2-selective inhibitors and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) is of worldwide concern. COX-2 inhibitors and NSAIDs act by inhibiting arachidonic acid metabolism to prostaglandins.